39 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
1995900	4	Romazarit: a potential disease-modifying antirheumatic drug.	Roche Products
2496230	1	Antiinflammatory activity of a series of substituted 2,3-dihydro-6-hydroxypyrimido[2,1-f]purine-4,8(1H,9H)-diones.	Schering-Plough
3086558	4	Antiinflammatory activity of substituted 6-hydroxypyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-triones. Atypical nonsteroidal antiinflammatory agents.	TBA
6502598	1	Bulky amine analogues of ketoprofen: potent antiinflammatory agents.	TBA
7332706	24	2,3-Dihydrobenzofuran-2-ones: a new class of highly potent antiinflammatory agents.	TBA
6772786	3	Synthesis and antiinflammatory activity of some 2-(substituted-pyridinyl)benzimidazoles.	TBA
23266122	47	Novel benzoxazole inhibitors of mPGES-1.	Pfizer
1848292	116	Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity.	Ici Pharmaceuticals Group
24900213	25	Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists.	TBA
1433181	39	Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitors.	Warner-Lambert
1635053	47	5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.	Wyeth-Ayerst Research
2113951	134	1,2-Dihydro-1-oxopyrrolo[3,2,1-kl]phenothiazine-2-carboxamides and congeners, dual cyclooxygenase/5-lipoxygenase inhibitors with antiinflammatory activity.	Pfizer
	8	Synthesis and biological evaluation of both enantiomers of L-761,000 as inhibitors of cyclooxygenase 1 and 2	TBA
	24	From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors	TBA
	11	Cyclooxygenase and 5-lipoxygenase inhibitory activity of 2,6 di-t-butylphenols linked by a sulfur atom to 1,3,4-thiadiazoles and 1,3,4-oxadiazoles	TBA
	11	Synthesis and cyclooxygenase and 5-lipoxygenase inhibitory activity of some thiazolidene-4-one analogs of meclofenamic acid	TBA
	16	Synthesis of reversed hydroxamic acids of indomethacin: dual inhibitors of cyclooxygenase and 5-lipoxygenase	TBA
	21	1-Phenyl-[2H]-tetrahydropyridazin-3-one, A-53612, a selective orally active 5-lipoxygenase inhibitor	TBA
	14	Conversion of NSAIDS into balanced dual inhibitors of cyclooxygenase and 5-lipoxygenase	TBA
11591502	51	Naphthalene derivatives: A new series of selective cyclooxygenase-2 inhibitors.	RhôNe-Poulenc Rorer
10230624	110	N-hydroxyurea and hydroxamic acid inhibitors of cyclooxygenase and 5-lipoxygenase.	The R. W. Johnson Pharmaceutical Research Institute
28530811	13	Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases.	University of Pennsylvania
8515419	29	1,3,4-Oxadiazole, 1,3,4-thiadiazole, and 1,2,4-triazole analogs of the fenamates: in vitro inhibition of cyclooxygenase and 5-lipoxygenase activities.	Warner-Lambert
30496988	25	Pharmaceutical and medicinal significance of sulfur (S	Wuhan University of Technology
10821716	31	Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (gamma-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase.	Shionogi
3806620	16	Leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Synthesis of benzoheterocyclic [(methoxyphenyl)amino]oxoalkanoic acid esters.	TBA
3091830	41	Selective thromboxane synthetase inhibitors. 4. 2-(1H-imidazol-1-ylmethyl) carboxylic acids of benzo[b]furan, benzo[b]thiophene, indole, and naphthalene.	TBA
3090264	28	Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitors.	TBA
28835803	14	Evaluation of Oxetan-3-ol, Thietan-3-ol, and Derivatives Thereof as Bioisosteres of the Carboxylic Acid Functional Group.	University of Pennsylvania
2502629	90	Differential effects of a series of hydroxamic acid derivatives on 5-lipoxygenase and cyclooxygenase from neutrophils and 12-lipoxygenase from platelets and their in vivo effects on inflammation and anaphylaxis.	Rorer Central Research
2498516	4	N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structure.	Wyeth-Ayerst Research
29031075	42	Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities.	Damanhour University
2213827	73	Penta- and hexadienoic acid derivatives: a novel series of 5-lipoxygenase inhibitors.	Centre De Recherches De Vitry
2115589	22	Antiinflammatory agents. 4. Syntheses and biological evaluation of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid and 2-amino-3-(4-chlorobenzoyl)benzeneacetic acid.	A.H. Robins
2115586	29	Nonsteroidal antiinflammatory drug hydroxamic acids. Dual inhibitors of both cyclooxygenase and 5-lipoxygenase.	Warner-Lambert
2104935	10	N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structure.	Wyeth-Ayerst Research
28757100	38	Design, synthesis and bioactivities of Celecoxib analogues or derivatives.	Chongqing Normal University
1847426	56	Styrylpyrazoles, styrylisoxazoles, and styrylisothiazoles. Novel 5-lipoxygenase and cyclooxygenase inhibitors.	Warner-Lambert